Universal Health Services, Inc.

Valuation Analysis

About the Company

Universal Health Services, Inc. en bref

Universal Health Services, Inc. (UHS) is currently trading at 123,01 € with a market capitalization of 7,4 Md €. The trailing P/E ratio stands at 5.89x, with a forward P/E of 5.57x. The 52-week range spans from 122,12 € to 214,74 €; the current price is 42.7% below the yearly high. Year-over-year revenue growth stands at +9.6%. The net profit margin stands at 8.56%.

💰 Dividende

Universal Health Services, Inc. pays an annual dividend of 0,70 € per share, representing a yield of 0.57%. The payout ratio stands at 3.34%.

📊 Avis des analystes

17 analystes évaluent Universal Health Services, Inc. (UHS) au consensus : Acheter. L'objectif de cours moyen est de 188,09 €, soit un potentiel de +52.91% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 143,84 € à 270,25 €.

Universal Health Services, Inc. : la thèse d'investissement en détail

Universal Health Services, Inc. (UHS) operates in the Healthcare — specifically Medical Care Facilities — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

Le scénario haussier

Wall Street consensus sits at Buy with an average price target implying roughly 52.91% upside from current levels — analyst sentiment is firmly constructive. Our valuation screen flags the stock as undervalued relative to its fundamentals — multiples are running below where the cash flow profile would normally justify.

Valorisation en contexte

The PEG ratio at 1.02 sits in the reasonable zone — the price tag is roughly aligned with the company's growth profile, neither punishing nor euphoric. The EV/EBITDA multiple of 5.26x is below the historical equity-market average — strategic acquirers would find the cash-flow profile attractive at this level.

À surveiller

• The price sits in the lower quartile of the 52-week range — value hunters often start scaling in around this zone if fundamentals hold.
• The analyst consensus price target implies 52.91% upside — if the next two quarters confirm the underlying thesis, target hikes typically follow.

Thèse d'investissement : forces et faiblesses

Aperçu technique

Price is below both the 50- and 200-day moving averages, with 50d below 200d — a bearish picture (death-cross alignment).

Profil de risque

The data points to market-like volatility, elevated short interest (7.03%).

Trading Data

💵 Dividend Info

Related Stocks in the Same Sector

Where can I buy Universal Health Services, Inc.?

Compare top-rated brokers — low fees, trusted providers, fully regulated.